Financials

  • Market Capitalization 208.63 M
  • Employee 81
  • Founded 1999
  • CEO N/A
  • Website www.agenusbio.com
  • Headquarter Delaware, United States
  • FIGI BBG000C8SWQ9
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
1.63
Rapporto prezzo/fatturato
0.86

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3601
RNA
Atrium Therapeutics, Inc. - Common Stock
12.32 USD+0.82%-7.85%-3.37%-82.48%210.74 M USD
3618
IMUX
Immunic, Inc. - Common Stock
15.00 USD+2.11%+1.56%+6.16%+1685.71%204.32 M USD
3628
CLLS
Cellectis S.A. - American Depositary Shares
2.81 USD-2.43%-9.65%-10.79%+42.64%201.62 M USD
3633
NERV
Minerva Neurosciences, Inc - Common Stock
4.33 USD+7.71%-6.28%-1.37%+147.43%201.73 M USD

Notizie